InspireMD Inc (NSPR) - Total Liabilities
Based on the latest financial reports, InspireMD Inc (NSPR) has total liabilities worth $14.36 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does InspireMD Inc generate cash to assess how effectively this company generates cash.
InspireMD Inc - Total Liabilities Trend (2008–2024)
This chart illustrates how InspireMD Inc's total liabilities have evolved over time, based on quarterly financial data. Check NSPR cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
InspireMD Inc Competitors by Total Liabilities
The table below lists competitors of InspireMD Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mirza International Limited
NSE:MIRZAINT
|
India | Rs1.73 Billion |
|
OssDsign AB
ST:OSSD
|
Sweden | Skr87.84 Million |
|
Cenit Co. Ltd
KQ:037760
|
Korea | ₩125.10 Billion |
|
Sietel Ltd
AU:SSL
|
Australia | AU$9.16 Million |
|
Grand Hall Enterprise Co Ltd
TWO:8941
|
Taiwan | NT$937.59 Million |
|
Brand Group (M.G) Ltd
TA:BRND
|
Israel | ILA615.29 Million |
Liability Composition Analysis (2008–2024)
This chart breaks down InspireMD Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NSPR market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how InspireMD Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for InspireMD Inc (2008–2024)
The table below shows the annual total liabilities of InspireMD Inc from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $10.72 Million | +31.68% |
| 2023-12-31 | $8.14 Million | +12.15% |
| 2022-12-31 | $7.26 Million | +17.48% |
| 2021-12-31 | $6.18 Million | +10.08% |
| 2020-12-31 | $5.61 Million | +24.84% |
| 2019-12-31 | $4.50 Million | +27.57% |
| 2018-12-31 | $3.52 Million | +4.29% |
| 2017-12-31 | $3.38 Million | -37.00% |
| 2016-12-31 | $5.37 Million | -38.50% |
| 2015-12-31 | $8.72 Million | -38.76% |
| 2014-12-31 | $14.25 Million | -7.05% |
| 2013-12-31 | $15.33 Million | +44.21% |
| 2012-12-31 | $10.63 Million | 0.00% |
| 2012-06-30 | $10.63 Million | 0.00% |
| 2011-12-31 | $10.63 Million | +128802.37% |
| 2010-12-31 | $8.24K | 0.00% |
| 2009-12-31 | $8.24K | +153.69% |
| 2008-12-31 | $3.25K | -- |
About InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding car… Read more